These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33704861)

  • 1. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth.
    Pam N; Kridin K; Khamaysi Z
    Dermatol Ther; 2021 May; 34(3):e14936. PubMed ID: 33704861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study.
    Kridin K; Pam N; Bergman R; Khamaysi Z
    Dermatol Ther; 2020 May; 33(3):e13331. PubMed ID: 32216160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound Growth of Infantile Hemangiomas After Propranolol Therapy.
    Shah SD; Baselga E; McCuaig C; Pope E; Coulie J; Boon LM; Garzon MC; Haggstrom AN; Adams D; Drolet BA; Newell BD; Powell J; García-Romero MT; Chute C; Roe E; Siegel DH; Grimes B; Frieden IJ
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26952504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of poor response to oral propranolol in infantile hemangiomas.
    Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
    Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
    Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
    Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
    Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
    Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
    Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
    Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol and infantile hemangiomas four years later: a systematic review.
    Marqueling AL; Oza V; Frieden IJ; Puttgen KB
    Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
    Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
    J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of infantile hemangiomas-experience of a tertiary hospital.
    Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
    Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel topical nano-propranolol for treatment of infantile hemangiomas.
    Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
    Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
    Olsen GM; Hansen LM; Stefanko NS; Mathes E; Puttgen KB; Tollefson MM; Lauren C; Mancini AJ; McCuaig CC; Frieden IJ; Adams D; Baselga E; Chamlin S; Gupta D; Frommelt P; Garzon MC; Horii K; Klajn J; Maheshwari M; Newell B; Nguyen HL; Nopper A; Powell J; Siegel DH; Drolet BA
    JAMA Dermatol; 2020 Feb; 156(2):186-190. PubMed ID: 31825455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
    Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
    Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate.
    Léauté-Labrèze C; Frieden I; Delarue A
    Pediatr Dermatol; 2023 Mar; 40(2):261-264. PubMed ID: 36511888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
    Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
    Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol.
    Johansen ML; Mahendran G; Lawley LP
    Pediatr Dermatol; 2021 Jul; 38(4):800-805. PubMed ID: 34115417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.